Colistimethate Sodium for Injection 1 MIU
Pack Sizes Available
Product Description
Technical Specifications
- Active Ingredient: Colistimethate Sodium (colistin prodrug)
- Strength: 1 MIU (1 Million International Units) per vial
- Dosage Form: Lyophilized powder for reconstitution
- Administration Route: Intravenous infusion (some formulations also support inhalation use)
- Drug Class: Polymyxin antibiotic
- Storage Condition: Store below 25 degrees C, protect from light
- Shelf Life: 24 months from date of manufacture
- Primary Use Case: Multidrug-resistant gram-negative bacterial infections
Colistimethate Sodium is reserved for serious infections caused by multidrug-resistant gram-negative bacteria such as Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter baumannii, typically when other antibiotics have failed or are not suitable. It is commonly used in intensive care settings for hospital-acquired pneumonia, bloodstream infections, and complicated urinary tract infections.
Colistimethate carries a meaningful risk of kidney toxicity and neurotoxicity, which led to it being used sparingly once safer alternatives became available. As bacterial resistance to newer antibiotics has increased, colistin has returned to clinical use specifically for cases where no better-tolerated option remains effective, and its use is generally reserved for exactly those situations.
The 1 MIU vial is often used for weight-based dosing calculations in smaller patients or where a precise lower total dose is needed, allowing clinicians to combine vials to reach the exact prescribed amount rather than working with partial higher-strength vials. Dosing is calculated based on renal function and body weight under close medical supervision.
Because of its narrow therapeutic index, patients on Colistimethate are usually monitored closely for kidney function through regular serum creatinine checks, along with observation for signs of neurotoxicity such as dizziness or muscle weakness. Dose adjustments are common as treatment progresses based on these results.
Unopened vials should be stored at or below 25 degrees Celsius, protected from light and moisture, in their original packaging. Once reconstituted, the solution should be used within the timeframe specified by the manufacturer and any unused solution discarded rather than stored for a later dose.
Many export packs include a companion ampoule of Water for Injection alongside the vial, though some institutional orders supply the vial alone for hospitals that maintain their own diluent stock. Buyers should confirm which configuration they require when placing an order.
Caspofungin Acetate for Injection
Fungal infections rarely wait for the perfect moment. They show up in ICUs, in oncology wards, in patients whose immune systems are already fighting three other battles, and clinicians need an antifungal that works fast without adding a fourth problem to the list. Caspofungin Acetate belongs to the echinocandin class, and unlike the older azole and polyene antifungals, it goes after the fungal cell wall rather than the cell membrane, which gives it a cleaner safety profile in patients who are already on a stack of other medications. Each vial is supplied as a lyophilized powder that gets reconstituted before intravenous infusion. Dosing typically follows a single 70mg loading dose on day one, then 50mg daily thereafter, which is exactly why exporters who understand hospital procurement stock both strengths together rather than forcing a buyer to source them separately. It treats invasive candidiasis, candidemia, esophageal candidiasis, and invasive aspergillosis in patients who haven't responded to or can't tolerate other therapies, making it a mainstay in tertiary care antifungal protocols across markets that import from India. What tends to matter most for an importer stocking this molecule is consistency between batches. Echinocandins are notoriously fussy to manufacture at scale, and a supplier who can't hold potency and reconstitution behavior steady from lot to lot creates real clinical risk downstream. We work with WHO-GMP compliant manufacturing partners who maintain tight cold-chain discipline from lyophilization through final packing, because a vial that arrives even slightly out of spec is a vial a hospital pharmacy will reject on sight. Regulatory paperwork for critical care antifungals gets scrutinized more than most, so every batch ships with a complete dossier: certificate of analysis, stability data, GMP certification, and where required, a free sale certificate that clears customs without the back-and-forth that stalls shipments for weeks. That documentation discipline, paired with flexible minimum order quantities that don't force smaller distributors into warehousing more stock than they can move, is what keeps repeat buyers coming back rather than shopping around every quarter. Fifteen years of exporting critical care injectables from India has taught us that price matters, but reliability of supply matters more when a hospital's antifungal stewardship program depends on a molecule actually being on the shelf when it's needed. Communication stays direct and personal rather than routed through layers of account managers, so questions about batch availability, lead times, or documentation get answered by someone who actually knows the shipment, not a call center script. For distributors serving hospital pharmacies, oncology centers, and critical care units, Caspofungin Acetate represents one of those products where the margin on any single vial is modest but the relationship built around dependable supply pays off across every reorder cycle that follows.
Colistimethate Sodium for Injection 2 MIU
Ask any ICU pharmacist which antibiotics they hope they never have to reach for, and colistin usually makes the list, not because it doesn't work but because reaching for it means the infection has already outsmarted the safer first-line options. Colistimethate Sodium in the 2 MIU strength is the middle ground most institutional pharmacies keep in stock, sized to cover a typical adult dose without requiring a nurse to reconstitute and combine multiple smaller vials at 3am. The drug itself is a polymyxin antibiotic, active against the gram-negative organisms that cause the most stubborn hospital-acquired infections: ventilator-associated pneumonia, bloodstream infections in ICU patients, and complicated UTIs where Pseudomonas or carbapenem-resistant Enterobacteriaceae have already defeated the usual regimen. It's not a first date kind of drug. It's the one you call when everything else has been tried. Because colistin's therapeutic window sits close to its toxic threshold, the strength stocked matters as much as the drug itself. A 2 MIU vial lets clinical staff dose more precisely without wasting product or splitting vials mid-shift, which sounds like a small operational detail until you're the pharmacy tech doing it for the fourth time in a night. We supply this strength specifically because importers have told us, repeatedly, that it's the one their hospital customers actually reorder most. Manufacturing colistin at consistent potency requires tight process control, and we source exclusively from partners holding WHO-GMP certification with documented cold-chain handling from lyophilization onward. Every shipment carries a full certificate of analysis, stability data package, and the regulatory documentation that customs and hospital procurement teams require before a critical care antibiotic clears their system, because incomplete paperwork on a last-resort antibiotic gets flagged faster than on almost any other product category. Demand for this molecule tends to spike unpredictably, tied to local resistance surveillance data rather than a steady calendar, so we keep order quantities flexible rather than forcing distributors into bulk commitments that don't match their actual tender cycles. Fifteen years in the export business has made one thing clear: the relationships that last are the ones where a distributor can call, ask a direct question about batch documentation or lead time, and get a straight answer from someone who actually knows the shipment. For wholesalers and hospital suppliers who need a dependable source of last-line gram-negative coverage, Colistimethate Sodium 2 MIU rounds out a critical care antibiotic portfolio in the strength that clinical teams reach for most often.
Clarithromycin for Injection 500mg
A patient who can't swallow a tablet still needs their pneumonia treated, and that's the entire reason Clarithromycin exists in injectable form. Oral clarithromycin has been a workhorse macrolide antibiotic for decades, but hospitalised patients on ventilators, those in post-surgical recovery, or anyone with a compromised gut can't rely on a pill making it past the stomach lining, which is where the IV formulation earns its place on the hospital formulary. Each 500mg vial contains clarithromycin lactobionate, reconstituted first with sterile water and then diluted further before administration as a slow IV infusion, never as a bolus injection and never intramuscularly. It's indicated for community-acquired pneumonia, bacterial bronchitis, and skin or soft tissue infections where oral therapy isn't practical, and it retains the broad gram-positive and gram-negative coverage that makes macrolides useful across a wide range of respiratory infections. The reconstitution chemistry on this molecule is genuinely finicky. It requires the correct diluent in the correct sequence, or the solution precipitates, and a batch that doesn't dissolve cleanly is a batch a hospital pharmacist sends straight back. We work with manufacturers who've refined their lyophilization and fill process specifically to avoid this problem, which sounds like a minor technical point until you're the distributor explaining to a hospital why half a shipment came back. For importers stocking hospital antibiotic ranges, having a supplier who can move quickly on documentation matters just as much as the product itself. Every batch we export ships with certificate of analysis, GMP compliance certification, and stability data covering the full claimed shelf life, so customs clearance and hospital pharmacy intake don't stall waiting on missing paperwork. Flexible order quantities mean a smaller regional distributor can stock a reasonable volume without committing to a container load they can't move before expiry. What distinguishes Clarithromycin for Injection from some of the flashier newer antibiotics is that demand for it is steady rather than spiky, tied to routine respiratory infection season rather than resistance outbreaks, which makes it a dependable, predictable line item for a distributor building a recurring order pattern. After 15 years exporting hospital-grade injectables from India, that predictability is exactly the kind of product relationship that keeps a partnership going year after year, backed by clear communication and delivery timelines a buyer can actually plan around. For hospital suppliers and pharmaceutical wholesalers rounding out a respiratory antibiotic portfolio, this 500mg vial fills the gap between oral therapy and the heavier IV antibiotics reserved for resistant infections.